Taran Therapeutics Reports Publication of ASH Abstracts for Clinical Treatment with Lenzilumab in Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia

Taran Therapeutics

7 min read

Taran Therapeutics Presents Promising Data from PREACH-M Trial for Chronic Myelomonocytic Leukemia and Secondary Acute Myeloid Leukemia Treatment

Taran Therapeutics

8 min read

Taran Therapeutics Reports Publication from PREACH-M Trial for Chronic Myelomonocytic Leukemia in Current Edition of the European Medical Journal

Taran Therapeutics

8 min read

Publication of Provisional Patent Application for Lenzilumab in Chronic Myelomonocytic Leukemia (CMML)

Taran Therapeutics

4 min read